The rift between the institutional pro-life movement and the Trump administration is growing wider as the administration continues to resist red-state efforts to restrict the availability of abortion pills.
Florida and Texas sued the Food and Drug Administration last year over the agency’s approval of the abortion drug Mifepristone. On Monday, the Department of Justice asked a judge to either dismiss the suit or delay a decision until the FDA has time to complete a new safety review of the drug, which was originally approved in 2000 and was made available by mail by the Biden administration during the Covid era.






Comments